PAF1 and Parkinson disease: The cytoprotective properties displayed in vitro by PD2 demonstrate the validity of such compounds to protect cells against the consequences of mitochondrial dysfunction such as that which are seen in the brain cells from patients with PD (Reelfs et al. 2019b).